Navigation Links
BioMS Medical's relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
Date:11/7/2007

forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
5. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
6. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
7. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
8. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 Two separate delegations of ... by Charm Sciences at its Andover, Massachusetts facility ... the US, the participants discussed international systems for ... and process verification, and received hands-on technical training ... the first visit to the United States for ...
(Date:10/31/2014)... The report "Dairy Alternative (Beverage) ... Flavored, Sweetened, Unsweetened), Channel (Supermarket, Health Store, Pharmacy, ... Forecast to 2018," defines and segments the dairy ... of revenue and volume for plant-based dairy alternative ... reach $14 Billion by 2018 with the Asia-Pacific ...
(Date:10/31/2014)... , Oct. 31, 2014  Tavistock Development Co. ... Tavistock Group, celebrated the groundbreaking of the GuideWell ... The 92,000-square-foot, three-story facility is ... Florida designed specifically for life sciences, ... heart of the 650-acre Lake Nona Medical City, ...
(Date:10/30/2014)...  Ardelyx, Inc. (NASDAQ: ARDX ), ... and metabolic diseases, today announced that it will ... November 6, 2014. Following the announcement, the Ardelyx ... and webcast at 4:30pm ET to review the ... The live webcast can be accessed ...
Breaking Biology Technology:Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 2GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 3Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2
... Medicine Labels for ... May 6 Summer is fast,approaching, bringing sunshine, vacation days, ... a peak in seasonal allergies and the,beginning of a busy ... Americans believe they will spend some time driving this Memorial,Day ...
... prevents wastage by saving the patient,s own whole blood, ... in a journal for,perfusionists, the health professionals who manage ... surgery, reports how Global Blood,Resources, online waste calculator can ... with the "cell washing" machines most commonly used,during heart ...
... of 60 Companies Selected to Participate at the "Facing ... Marking the Country,s 60th Birthday, JERUSALEM, Israel, May ... oral delivery systems,has been selected for the first annual ... of tomorrow" representing the,future face of Israel. The monumental ...
Cached Biology Technology:Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season 2Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season 3Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions 2Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions 3Israel's Prestigious President's Conference to Feature Oramed Pharmaceuticals' Revolutionary Oral Insulin Capsule 2
(Date:10/31/2014)... WCS study confirms that endangered musk deer still live ... sighting, Species targeted by poachers: Musk deer scent glands ... the October issue of the journal Oryx ... 60 years after its last confirmed sighting, a strange ... forested slopes of northeast Afghanistan according to a research ...
(Date:10/31/2014)... Planting trees and creating green space in cities is good ... ensure biodiversity in built environments, a University of Iowa study ... in an urban area in Iowa, and recorded the abundance ... while there were plenty of the trees, black cherry and ... insects, in this case fruit flies that feed on the ...
(Date:10/31/2014)... team have been studying the behavior of approximately ... for years. They observed that ravens slowly build ... playing. However, they also observed that these affiliative ... Although in about 50 % of the cases ... two affiliating ravens, intervening can be potentially risky ...
Breaking Biology News(10 mins):Strange, fanged deer persists in Afghanistan 2Green spaces don't ensure biodiversity in urban areas 2
... 22, 2011 Los Alamos National Laboratory scientists have won ... the "Oscars of Invention" by the Chicago Tribune, these ... the past year. The winning Laboratory technologies include a ... fluid for oil wells that shrinks when heated, and ...
... Concordians have received prestigious awards from the Natural Sciences ... Nadia Bhuiyan and Yves Glinas are the recipients of ... Bhuiyan, a professor in the Department of Mechanical and ... of Aerospace Design and Innovation, specializes in operations management ...
... athletic fields with sand has been used by turfgrass ... and healthy turf, and using porous sand allows the ... adequate drainage, even in heavy foot traffic. While ... municipalities, conversion to a sand-based system is expensive. Complete ...
Cached Biology News:Los Alamos National Laboratory earns 3 R&D 100 Awards 2Los Alamos National Laboratory earns 3 R&D 100 Awards 3Concordia research accelerated 2Optimal topdressing applications for athletic fields determined 2
... Human, Assay, 96 wells. ELISA.Specific for ... complexed MMP-3. No cross-reactivity with MMP-1, -2, ... for use with cell culture supernatant, serum, ... -15 to -30 C. Category: Drug ...
... from different human fetal normal tissues ... available upon request. Customers can ... whole set, and pay 70% of ... Dr. P Set products are for ...
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Self Closing Forceps...
Biology Products: